封面
市场调查报告书
商品编码
1671860

人类原代细胞培养市场:依产品类型、细胞类型、应用和最终用户分类

Human Primary Cell Culture Market, By Product Type, By Cell Type, By Application, By End User

出版日期: | 出版商: Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球人类原代细胞培养市场规模估计为 41 亿美元,预计到 2032 年将达到 86.1 亿美元,2025 年至 2032 年的复合年增长率为 11.2%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 41亿美元
效能资料 从 2020 年到 2024 年 预测期 2025 至 2032 年
预测期:2025-2032年复合年增长率: 11.20% 2032 年价值预测 86.1亿美元
数字。 2025 年人类原代细胞培养市场占有率(%)
人类原代细胞培养市场-IMG1

原代人体细胞培养是指在人工、受控的环境中直接从体内培养人体细胞或组织。在过去的几十年里,分离和培养人类原代细胞的技术取得了重大进展。原代细胞培养使研究人员能够在生物体外部的培养皿中研究单一细胞类型及其对各种刺激的反应。这可以减少研究中使用动物和人类受试者,同时深入了解疾病过程并测试潜在的治疗方法。原代细胞保留了其来源生物体特定细胞的特征,并具有与该生物体相似的代谢。全球人类原代细胞培养市场因其在癌症、干细胞、组织工程和药物发现相关研究中的广泛应用而受到关注。

市场动态:

全球人类原代细胞培养市场受到医药研发活动的活性化、政府对医疗保健研究的支出增加以及慢性病盛行率上升的推动。原代细胞培养在癌症等各种疾病的个人化药物开发中发挥重要作用。然而,分离程序的高成本和细胞培养实验室的基础设施要求限制了市场的成长。另一个挑战是缺乏处理原代细胞的熟练专业人员。从积极的一面来看,培养基配方的技术进步可以更好地模拟体内微环境,从而提供机会。预计预测期内,利用原代细胞的 3D 生物列印技术和器官晶片平台的开发将进一步推动市场扩张。

本研究的主要特点

本报告对全球人类原代细胞培养市场进行了详细分析,并提供了预测期(2025-2032)的市场规模和年复合成长率(CAGR%),假设 2024 年为基准年。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球人类原代细胞培养市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行介绍的。

研究涉及的主要企业包括赛默飞世尔科技、默克公司、龙沙集团、丹纳赫集团、碧迪公司、康宁公司、赛多利斯公司、通用电气医疗集团、富士欧文科学公司、西格玛奥德里奇公司(默克公司)、PromoCell GmbH、美国典型培养物保藏中心(ATCC)、Cell Biologics、VivoVivos、Stem Technologies等。

从本报告中获得的见解将使企业负责人和高阶主管能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

用于分析全球人类原代细胞培养市场的各种策略矩阵将有助于相关人员做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 限制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • PORTER 分析
  • 併购情景
  • 产业趋势

4. 2020 年至 2032 年全球人类原代细胞培养市场(依产品类型)

  • 初代细胞
  • 乐器
  • 试剂和补充剂
  • 原代细胞培养基
  • 其他耗材

5. 全球人类原代细胞培养市场(依细胞类型划分),2020 年至 2032 年

  • 人类原代细胞
  • 动物原代细胞

6. 2020 年至 2032 年全球人类原代细胞培养市场(依应用划分)

  • 细胞和基因治疗的发展
  • 疫苗生产
  • 药物研发
  • 癌症研究
  • 产前检查
  • 其他的

7. 全球人类原代细胞培养市场,依最终用户划分,2020 年至 2032 年

  • 製药和生物技术公司
  • 学术研究所
  • 合约研究组织 (CRO)
  • 其他的

8. 全球人类原代细胞培养市场(按地区划分),2020 年至 2032 年

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza Group
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Corning Incorporated
  • Sartorius AG
  • GE Healthcare
  • Fujifilm Irvine Scientific
  • Sigma-Aldrich(Merck)
  • PromoCell GmbH
  • ATCC(American Type Culture Collection)
  • Cell Biologics
  • InVivo Biosystems
  • Stemcell Technologies

第 10 章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7724

The Global Human Primary Cell Culture Market is estimated to be valued at USD 4.10 Bn in 2025 and is expected to reach USD 8.61 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.10 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.20% 2032 Value Projection: USD 8.61 Bn
Figure. Human Primary Cell Culture Market Share (%), By Region, 2025
Human Primary Cell Culture Market - IMG1

Human primary cell culture refers to the practice of growing human cells and tissues directly extracted from the body in an artificial controlled environment. Over the past few decades, techniques of isolating and culturing primary human cells have advanced significantly. Primary cell cultures allow researchers to study individual cell types and their responses to various stimuli in a dish, outside a living organism. This reduces the use of animal and human subjects in research while providing insights into disease processes and testing potential therapeutic agents. Primary cells retain characteristics of the specific cell in the body from which they are derived and have metabolism resembling their in vivo counterparts. The global human primary cell culture market has been gaining traction due to its wide application in research related to cancer, stem cells, tissue engineering, and drug discovery.

Market Dynamics:

The global human primary cell culture market is driven by rising pharmaceutical R&D activities, increasing governmental expenditure on healthcare research, and growing prevalence of chronic diseases. Primary cell culture plays a critical role in developing personalized medicines for various conditions like cancer. However, high cost of isolation procedures and infrastructure requirements for cell culture laboratories limit the market growth. Shortage of skilled professionals to handle primary cells also poses a challenge. On the positive side, technological advancements in culture media formulations that better mimic the in vivo microenvironment offer opportunities. Adoption of 3D bioprinting techniques and development of organ-on-chip platforms utilizing primary cells would further support the market expansion during the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global human primary cell culture market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global human primary cell culture market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Danaher Corporation, Becton, Dickinson and Company, Corning Incorporated, Sartorius AG, GE Healthcare, Fujifilm Irvine Scientific, Sigma-Aldrich (Merck), PromoCell GmbH, ATCC (American Type Culture Collection), Cell Biologics, InVivo Biosystems, and Stemcell Technologies

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global human primary cell culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human primary cell culture market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Primary Cells
    • Instruments
    • Reagents and Supplements
    • Primary Cell Culture Media
    • Other Consumables
  • Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Human Primary Cells
    • Animal Primary Cells
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Cell & Gene Therapy Development
    • Vaccine Production
    • Drug Discovery and Development
    • Cancer Research
    • Prenatal Diagnosis
    • Others
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutions
    • Contract Research Organizations (CROs)
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific
    • Merck KGaA
    • Lonza Group
    • Danaher Corporation
    • Becton, Dickinson and Company
    • Corning Incorporated
    • Sartorius AG
    • GE Healthcare
    • Fujifilm Irvine Scientific
    • Sigma-Aldrich (Merck)
    • PromoCell GmbH
    • ATCC (American Type Culture Collection)
    • Cell Biologics
    • InVivo Biosystems
    • Stemcell Technologies

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Human Primary Cell Culture Market, By Product Type
    • Global Human Primary Cell Culture Market, By Cell Type
    • Global Human Primary Cell Culture Market, By Application
    • Global Human Primary Cell Culture Market, By End User
    • Global Human Primary Cell Culture Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Human Primary Cell Culture Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Primary Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Reagents and Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Primary Cell Culture Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Human Primary Cell Culture Market, By Cell Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Human Primary Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Animal Primary Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Human Primary Cell Culture Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cell & Gene Therapy Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Vaccine Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cancer Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prenatal Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Human Primary Cell Culture Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Human Primary Cell Culture Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corning Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sartorius AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
  • Fujifilm Irvine Scientific
  • Sigma-Aldrich (Merck)
  • PromoCell GmbH
  • ATCC (American Type Culture Collection)
  • Cell Biologics
  • InVivo Biosystems
  • Stemcell Technologies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us